Title: Sleep Quality and Pattern in Relation to the Severity of Chronic Obstructive Pulmonary Disease

Authors: Dr Suresh Patil, Dr Sarang Patil

 DOI:  https://dx.doi.org/10.18535/jmscr/v6i7.89

Abstract

Introduction: Patients with chronic obstructive pulmonary disease (COPD) frequently suffer from nocturnal alterations in gas exchange. The aim of the present study was to observe and describe the sleep pattern and quality in patients with varying severity of COPD.

Methodology: In this observational study we included all cases of known stable or newly diagnosed COPD on spirometry as per GOLD criteria with or without complaints of changes in sleep pattern or quality from January 1, 2018 till April 30, 2018. Demography, past medical history, clinical presentation and anthropometry were noted. Polysomnography was performed using standard techniques and manually analysed.

Results: During the study period a total of 168 patients were included; 67% males and mean age 64.2 years. Mean sleep efficiency in mild COPD was 82.7%, moderate COPD was 83.1 % and in severe COPD was 94.3%. Sleep latency was decreased in severe COPD patients, normal in mild and moderate COPD. Mean duration of Stage N1 was 12.9%, 20.1% and 14.32% in mild, moderate and severe COPD respectively. Mean duration of Stage N2 was 30.2%, 32.1% and 42.6% in mild, moderate and severe COPD respectively. Mean duration of Stage N3 in mild COPD was 52%, in moderate COPD was 36.2% and in severe COPD was 25.5 % of total sleep time. Further, we observed that the mean duration of Stage R in mild COPD was 4.6 %, in moderate COPD was 3.7 % and in severe COPD was 5.9 % of total sleep time.

Conclusions: Clinicians need to be aware about the decreased quality of sleep in COPD patients. Good sleep hygiene and measures to improve sleep quality will  help to improve the quality of life of COPD patients.

Keywords: chronic obstructive pulmonary disease, sleep, sleep quality, insomnia.

References

  1. Casey KR, Cantillo KO, Brown LK. Sleep-related hypoventilation/hypoxemic syndromes. Chest 2007; 131:1936.
  2. Calverley PM, Rennard SI, Clerisme-Beaty E, et al. Effect of tiotropium on night-time awakening and daily rescue medication use in patients with COPD. Respir Res 2016; 17: 27.
  3. Calverley PM, Brezinova V, Douglas NJ, et al. The effect of oxygenation on sleep quality in chronic bronchitis and emphysema. Am Rev Respir Dis 1982; 126:206.
  4. Brown LK. Sleep-related disorders and chronic obstructive pulmonary disease. Respir Care Clin N Am 1998; 4:493.
  5. Chaouat A, Weitzenblum E, Krieger J, et al. Association of chronic obstructive pulmonary disease and sleep apnea syndrome. Am J Respir Crit Care Med 1995; 151:82.
  6. Rechtschaffen A, Kales A. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. US Government Printing Office, Public Health Service, Washington, 1968.
  7. Miller MR, Hankinson J, Brusasco V et al. Standardisation of spirometry. Eur. Respir. J. 2005; 26: 319–38.
  8. Pauwels RA, Buist AS, Calverley PMA, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care Med. 2001;163:1256–76
  9. Cormick W, Olson LG, Hensley MJ, Saunders NA. Nocturnal hypoxaemia and quality of sleep in patients with chronic obstructive lung disease. Thorax 1986;41(11):846–54.
  10. Klink M, Quan SF. Prevalence of reported sleep disturbances in a general adult population and their relationship to obstructive airways diseases. Chest 1987;91(4):540–6.
  11. Bellia V, Catalano F, Scichilone N, Incalzi RA, Spatafora M, Vergani C, et al. Sleep disorders in the elderly with and without chronic airflow obstruction: the SARA study. Sleep 2003;26(3):318–23.
  12. Fleetham J, West P, Mezon B, Conway W, Roth T, Kryger M. Sleep, arousals, and oxygen desaturation in chronic obstructive pulmonary disease. The effect of oxygen therapy. Am Rev Respir Dis 1982;126(3):429–33.
  13. Karachaliou F, Kostikas K, Pastaka C, Bagiatis V, Gourgoulianis KI. Prevalence of sleep-related symptoms in a primary care population – their relation to asthma and COPD. Prim Care Respir J 2007;16(4):222–8.
  14. Baik I, Kim J, Abbott RD, Joo S, Jung K, Lee S, et al. Association of snoring withchronic bronchitis. Arch Intern Med 2008;168(2):167–73.
  15. Price D, Small M, Milligan G, et al. Impact of night-time symptoms in COPD: a real-world study in five European countries. Int J Chron Obstruct Pulmon Dis 2013; 8: 595–603.
  16. McSharry DG, Ryan S, Calverley P, et al. Sleep quality in chronic obstructive pulmonary disease. Respirology 2012; 17: 1119–1124.
  17. Martin RJ, Bartelson BL, Smith P, et al. Effect of ipratropium bromide treatment on oxygen saturation and sleep quality in COPD. Chest 1999; 115: 1338–1345.
  18. McNicholas WT, Calverley PM, Lee A, et al. Long-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPD. Eur Respir J 2004; 23: 825–831.
  19. Ryan S, Doherty LS, Rock C, et al. Effects of salmeterol on sleeping oxygen saturation in chronic obstructive pulmonary disease. Respiration 2010; 79: 475–481.

Corresponding Author

Dr Sarang Patil

Junior Resident, Dept. of Pulmonary Medicine

Dr. D.Y. Patil Medical College, Nerul,

Navi Mumbai (400706), Maharashtra, India